total VC investment value was recorded at approximately nine million U.S. dollars, which was lower compared to manufacturing technology and IT sectors.
The value of an average venture capital investment deal in developing companies of the biotechnology sector in Russia decreased by 800 thousand U.S. dollars in the first half of 2019 compared to 12 months of 2018. With the mean deal value of 1.8 million U.S. dollars over the first six months of 2019, biotechnology's Average value of a venture capital deal in the biotechnology sector in Russia from 2017 to 1st half of 2019 (in million U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
9
- Premium Statistic Venture capital investment in Russia 2019-2022, by sector
- Premium Statistic Value of venture capital investment in Russia 2017-2022
- Premium Statistic Number of venture capital deals in Russia 2017-2022
- Premium Statistic Number of venture capital deals in Russia H1 2022, by stage
- Premium Statistic Value of venture capital exits in Russia 2017-2020
- Premium Statistic Venture capital investment in Russia H1 2022, by stage
- Premium Statistic Value of venture capital investment in IT in Russia H1 2019, by stage
- Premium Statistic Average venture capital deal value in manufacturing technology in Russia 2017-2019
- Premium Statistic Russian venture capital investment abroad 2017-2019, by sector
About the region
10
- Premium Statistic Average venture capital deal value in Russia 2022, by stage
- Premium Statistic Venture capital investment value in Russia 2021-2022, by investor type
- Premium Statistic Average venture capital deal value in Russia 2017-2019
- Premium Statistic Russian venture capital investment abroad in H1 2019, by stage
- Premium Statistic Value of venture capital investment in Russia H1 2022, by industry
- Premium Statistic Largest investment deals in Russia H1 2022, by value
- Premium Statistic Venture capital investment in ICT Russia 2015-2022
- Premium Statistic Value of grants awarded in Russia 2017-2020
- Premium Statistic Venture capital deals value in Russia H1 2020, by stage and investor type
- Premium Statistic Number of B2C venture capital deals in Russia 2020, by sector
Selected statistics
2
Other regions
10
- Premium Statistic Value of venture capital investment in the U.S. 2006-2022
- Premium Statistic Latin America: venture capital deals 2020, by country
- Premium Statistic Americas: VC investment value 2014-2022
- Premium Statistic Value of private equity deals in Canada in 2022, by industry
- Premium Statistic Chile: venture capital investment value 2015-2019
- Premium Statistic Peru: venture capital investment value 2015-2019
- Premium Statistic Value of alternative investments globally 2005-2013
- Premium Statistic Total value of investment in Fintech in Asia 2013-2016, by year
- Premium Statistic Value of investment in Fintech in North America 2011-2015, by type
- Premium Statistic Funding of BioTech companies in Brazil 2022
Related statistics
10
- Basic Statistic Environmental protection investment in Russia 2000-2022, by area
- Basic Statistic Environmental protection investment in Russia 2000-2022
- Premium Statistic Value at cost of venture capital divestments in CEE 2022, by exit type
- Premium Statistic Foreign direct investment (FDI) inward stock in EAEU 2010-2021
- Premium Statistic Foreign direct investment (FDI) outward stock in EAEU 2010-2021
- Premium Statistic EdTech venture capital investment in Russia 2017-2021
- Premium Statistic Value of commercial real estate investment in CEE 2007-2022
- Basic Statistic COVID-19 vaccination in Ukraine 2022, by producer & order
- Premium Statistic R&D expenditure as a GDP share in Russia 2001-2020
- Premium Statistic Russian oil and production modernization investment 2011-2018
Further related statistics
10
- Structure of investment portfolio of Allianz Group 2014-2023
- Biotech company distribution by geographical location
- MorphoSys' revenue 2006-2023
- MorphoSys' research & development expenditure 2006-2023
- Key figures on established biotech centers worldwide 2012-2016
- Foreign direct investment projects in African countries between 2003 and 2012
- Leading financial centers in Western Europe 2023
- Leading banks in the Middle East in 2023, by brand value
- Debt instruments in fixed income portfolio of Allianz Group 2015-2023
- Merck & Co total assets 2009-2023
Further Content: You might find this interesting as well
Statistics
- Structure of investment portfolio of Allianz Group 2014-2023
- Biotech company distribution by geographical location
- MorphoSys' revenue 2006-2023
- MorphoSys' research & development expenditure 2006-2023
- Key figures on established biotech centers worldwide 2012-2016
- Foreign direct investment projects in African countries between 2003 and 2012
- Leading financial centers in Western Europe 2023
- Leading banks in the Middle East in 2023, by brand value
- Debt instruments in fixed income portfolio of Allianz Group 2015-2023
- Merck & Co total assets 2009-2023
PwC, & Russian Venture Company. (September 13, 2019). Average value of a venture capital deal in the biotechnology sector in Russia from 2017 to 1st half of 2019 (in million U.S. dollars) [Graph]. In Statista. Retrieved April 27, 2024, from https://www.statista.com/statistics/1062323/average-venture-capital-deal-value-biotech-russia/
PwC, und Russian Venture Company. "Average value of a venture capital deal in the biotechnology sector in Russia from 2017 to 1st half of 2019 (in million U.S. dollars)." Chart. September 13, 2019. Statista. Accessed April 27, 2024. https://www.statista.com/statistics/1062323/average-venture-capital-deal-value-biotech-russia/
PwC, Russian Venture Company. (2019). Average value of a venture capital deal in the biotechnology sector in Russia from 2017 to 1st half of 2019 (in million U.S. dollars). Statista. Statista Inc.. Accessed: April 27, 2024. https://www.statista.com/statistics/1062323/average-venture-capital-deal-value-biotech-russia/
PwC, and Russian Venture Company. "Average Value of a Venture Capital Deal in The Biotechnology Sector in Russia from 2017 to 1st Half of 2019 (in Million U.S. Dollars)." Statista, Statista Inc., 13 Sep 2019, https://www.statista.com/statistics/1062323/average-venture-capital-deal-value-biotech-russia/
PwC & Russian Venture Company, Average value of a venture capital deal in the biotechnology sector in Russia from 2017 to 1st half of 2019 (in million U.S. dollars) Statista, https://www.statista.com/statistics/1062323/average-venture-capital-deal-value-biotech-russia/ (last visited April 27, 2024)
Average value of a venture capital deal in the biotechnology sector in Russia from 2017 to 1st half of 2019 (in million U.S. dollars) [Graph], PwC, & Russian Venture Company, September 13, 2019. [Online]. Available: https://www.statista.com/statistics/1062323/average-venture-capital-deal-value-biotech-russia/